The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Bonjela Teething Gel Oromucosal GelCholine Salicylate 8.714%Cetalkonium Chloride 0.010%



Reckitt Benckiser Ireland LtdPA0979/001/003

Main Information

Trade NameBonjela Teething Gel Oromucosal GelCholine Salicylate 8.714%Cetalkonium Chloride 0.010%
Active SubstancesCholine salicylate
Cetalkonium chloride
Dosage FormOromucosal gel
Licence HolderReckitt Benckiser Ireland Ltd
Licence NumberPA0979/001/003

Group Information

ATC CodeN02BA Salicylic acid and derivatives
N02BA03 choline salicylate

Status

License statusAuthorised
Licence Issued12/03/2010
Legal statusProduct not subject to medical prescription
Supply StatusSupply through non-pharmacy outlets and pharmacies
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back